Treatment of age-related macular degeneration.
Publication
, Journal Article
Cheung, CMG; Wong, TY
Published in: Lancet
October 12, 2013
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Lancet
DOI
EISSN
1474-547X
Publication Date
October 12, 2013
Volume
382
Issue
9900
Start / End Page
1230 / 1232
Location
England
Related Subject Headings
- Vascular Endothelial Growth Factor A
- Ranibizumab
- Male
- Humans
- General & Internal Medicine
- Female
- Choroidal Neovascularization
- Bevacizumab
- Antibodies, Monoclonal, Humanized
- Angiogenesis Inhibitors
Citation
APA
Chicago
ICMJE
MLA
NLM
Cheung, C. M. G., & Wong, T. Y. (2013). Treatment of age-related macular degeneration. Lancet, 382(9900), 1230–1232. https://doi.org/10.1016/S0140-6736(13)61580-9
Cheung, Chui Ming Gemmy, and Tien Y. Wong. “Treatment of age-related macular degeneration.” Lancet 382, no. 9900 (October 12, 2013): 1230–32. https://doi.org/10.1016/S0140-6736(13)61580-9.
Cheung CMG, Wong TY. Treatment of age-related macular degeneration. Lancet. 2013 Oct 12;382(9900):1230–2.
Cheung, Chui Ming Gemmy, and Tien Y. Wong. “Treatment of age-related macular degeneration.” Lancet, vol. 382, no. 9900, Oct. 2013, pp. 1230–32. Pubmed, doi:10.1016/S0140-6736(13)61580-9.
Cheung CMG, Wong TY. Treatment of age-related macular degeneration. Lancet. 2013 Oct 12;382(9900):1230–1232.
Published In
Lancet
DOI
EISSN
1474-547X
Publication Date
October 12, 2013
Volume
382
Issue
9900
Start / End Page
1230 / 1232
Location
England
Related Subject Headings
- Vascular Endothelial Growth Factor A
- Ranibizumab
- Male
- Humans
- General & Internal Medicine
- Female
- Choroidal Neovascularization
- Bevacizumab
- Antibodies, Monoclonal, Humanized
- Angiogenesis Inhibitors